Use Of Tazarotene Foam For The Treatment Of Acn...

Ustekinumab For The Treatment Of Psoriatic Arth...

A Randomized, Double-blind, Placebo-controlled ...

Emerging Permanent Filler Technologies: Focus O...

A Cosmeceutical Formulation Based On Boswellic ...

0 votes
Use Of Tazarotene Foam For The Treatment Of Acne Vulgaris
Author: Stamatis Gregoriou, Eleftheria Kritsotaki, Alexandros Katoulis, Dimitris Rigopoulos
Publisher: Derivative Works
6 pages
One time payment: €0.00
Required subscription: Free
Type of publication: Article
ISBN/ISSN: 1178-7015
DOI: 10.2147/CCID.S37327
Follow this publisher

Share this publication:


Abstract: Acne vulgaris is a common inflammatory chronic disease of the pilosebaceous unit. It often requires long-term treatment, resulting in increased demand for topical medications that are popular with patients in order to achieve long-term compliance. Tazarotene foam 0.1% is a novel formulation of tazarotene. We review efficacy and tolerability studies of the new formulation, and suggest a possible place for the product in the management of acne vulgaris.

About the publisher:

We are a publishing house devoted to reuse CC-BY licensed published materials.


Using CC-BY licenses:


  • Adapt — remix, transform, and build upon the material
  • for any purpose, even commercially.
  • The licensor cannot revoke these freedoms as long as you follow the license terms.


  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others
    from doing anything the license permits.


  • You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
  • No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

Select a payment method